COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,785 Articles (22,523 medRxiv, 8,262 bioRxiv)

Most recent first Previous |  Page 860: Articles 8591-8600  | Next

Health Provider and Sexual and Gender Minority Service User Perspectives on Provision of Mental Health Services During the Early Phase of the COVID-19 Pandemic in British Columbia, Canada
Kennedy, A. M., Black, S., Watt, S., Vitkin, N., Young, J., Reeves, R., Salway, T.
10.1101/2022.02.18.22271151 — Posted: 2022-02-25
A mixture model to estimate SARS-CoV-2 seroprevalence in Chennai, India
Hitchings, M. D. T., Patel, E. U., Khan, R., Srikrishnan, A. K., Anderson, M., Kumar, K. S., Wesolowski, A. P., Iqbal, S. H., Rodgers, M. A., Mehta, S. H., Cloherty, G., Cummings, D. A. T., Solomon, S. S.
10.1101/2022.02.24.22271002 — Posted: 2022-02-25
Risk of COVID-19 related deaths for SARS-CoV-2 Omicron (B.1.1.529) compared with Delta (B.1.617.2)
Ward, I. L., Bermingham, C., Ayoubkhani, D., Gethings, O. J., Pouwels, K., Yates, T., Khunti, K., Hippisley-Cox, J., Banerjee, A., Walker, A. S., Nafilyan, V.
10.1101/2022.02.24.22271466 — Posted: 2022-02-25
Protection of Omicron sub-lineage infection against reinfection with another Omicron sub-lineage
Chemaitelly, H., Ayoub, H. H., Coyle, P., Tang, P., YASSINE, H. M., Al-Khatib, H. A., Smatti, M. K., Hasan, M. R., Al-Kanaani, Z., Al-Kuwari, E., Jeremijenko, A., Kaleeckal, A. H., Latif, A. N., Shaik, R. M., Abdul-Rahim, H. F., Nasrallah, G., Al-Kuwari, M. G., Butt, A. A., Al-Romaihi, H. E., Al-Thani, M. H., Al-Khal, A., Bertollini, R., Abu-Raddad, L. J.
10.1101/2022.02.24.22271440 — Posted: 2022-02-25
Diabetes-related excess mortality in Mexico: a comparative analysis of national death registries between 2017-2019 and 2020
Bello-Chavolla, O. Y., Antonio-Villa, N. E., Fermin-Martinez, C. A., Fernandez-Chirino, L., Vargas-Vazquez, A., Ramirez-Garcia, D., Basile-Alvarez, M. R., Hoyos-Lazaro, A. E., Carrillo-Larco, R. M., Wexler, D. J., Manne-Goehler, J., Seiglie, J. A.
10.1101/2022.02.24.22271337 — Posted: 2022-02-25
Public Health Impact of the Pfizer-BioNTech COVID-19 vaccine (BNT162b2) in the first year of rollout in the United States
Di Fusco, M., Marczell, K., Deger, K. A., Moran, M. M., Wiemken, T. L., Cane, A., de Boisvilliers, S., Yang, J., Vaghela, S., Roiz, J.
10.1101/2022.02.24.22271478 — Posted: 2022-02-25
Highly divergent white-tailed deer SARS-CoV-2 with potential deer-to-human transmission
Pickering, B., Lung, O., Maguire, F., Kruczkiewicz, P., Kotwa, J. D., Buchanan, T., Gagnier, M., Guthrie, J., Jardine, C., Marchand-Austin, A., Masse, A., McClinchey, H., Nirmalarajah, K., Aftanas, P., Blais-Savoie, J., Chee, H.-Y., Chien, E., Yim, W., Goolia, M., Suderman, M., Pinette, M., Smith, G., Sullivan, D., Rudar, J., Adey, E., Nebroski, M., Cote, M., Laroche, G., McGeer, A., Nituch, L., Mubareka, S., Bowman, J.
10.1101/2022.02.22.481551 — Posted: 2022-02-25 Discussion: Onsite
Presence of Symptoms 6 Weeks After COVID-19 Among Vaccinated and Unvaccinated U.S. Healthcare Personnel
Mohr, N. M., Plumb, I. D., Harland, K. K., Pilishvili, T., Flemming-Dutra, K. E., Krishnadasan, A., Hoth, K. F., Saydah, S. H., Mankoff, Z., Haran, J. P., Briggs-Hagen, M., Santos Leon, E., Talan, D. A., Project PREVENT Network
10.1101/2022.02.16.22271092 — Posted: 2022-02-25
Psychosocial factors associated with mental health and quality of life during the COVID-19 pandemic among low-income urban dwellers in Peninsular Malaysia
Min Fui, W., Abdul Majid, H., Ismail, R., Su, T. T., Maw Pin, T., Said, M. A.
10.1101/2022.02.21.22271310 — Posted: 2022-02-25
Effectiveness of the third dose of BNT162b2 vaccine on neutralizing Omicron variant in the Japanese population
Kawasuji, H., Morinaga, Y., Tani, H., Saga, Y., Kaneda, M., Murai, Y., Ueno, A., Miyajima, Y., Fukui, Y., Nagaoka, K., Ono, C., Matsuura, Y., Niimi, H., Yamamoto, Y.
10.1101/2022.02.23.22271433 — Posted: 2022-02-25

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).